Massive transfusion protocol optimization by Smith, M. et al.
Massive Transfusion Protocol Optimization
OSU Medical Center Emergency Medicine
M. Smith, DO; J. Briggs, DO; R. Coker, DO; D. Blankenship, DO; M. Schiesel, DO; M. Cannon, DO; K. Murray, PharmD; J. Pritchett, DO
INTRODUCTION
Hemorrhage is a leading cause of mortality in 
trauma, accounting for up to 80% of 
intraoperative trauma mortalities and nearly 
half of the deaths that occur within 24 hours of 
traumatic injury.1 Use of a massive transfusion 
protocol allows for expedient resource 
utilization, organized workflow, and rapid task 
delegation in critical scenarios.2 Critical 
protocol components include ease of initiation, 
rapid access to blood products, clearly defined 
clinical roles, and easy tracking of metrics to 
reduce iatrogenic coagulopathy.3
OBJECTIVES
As a cooperative effort between the hospital 
medical staff, nursing staff, pharmacy staff, and 
blood bank, an updated protocol was 
developed, emphasizing current research on 
blood product administration, protocols of 
blood supply chains, and with the intention to 
simplify the activation and delivery of blood 
products in the emergency setting. 
METHODS
As massive transfusion is a well-researched and 
documented topic, a literature review was 
conducted to gather recommendations on 
blood product administration ratios and 
methodologies for activation of a massive 
transfusion protocol.4
The existing OSUMC Massive Transfusion 
Protocol was reviewed and residents, attending 
physicians, nurses, and blood bank personnel 
were surveyed for points of potential conflict 
or hindrance toward delivery of blood products 
with previous policy.
A new Massive Transfusion Protocol was 
drafted, emphasizing ease of activation, 
clarification of staff roles, and rapid delivery of 
products in massive transfusion. The final draft 
of the Massive Transfusion Protocol was 
submitted to the OSUMC Transfusion 
Committee for approval. Following approval, 
medical, nursing and blood bank staff were 
provided training on new protocol prior to 
initiation.
Following training of staff on the new Massive 
Transfusion Protocol, a new MTP Initiation order 
was deployed in the EHR and go-live was 
announced.
Activation of the Massive Transfusion Protocol is 
now possible through single physician order and 
blood products are serially delivered by blood 
bank until order to stop Massive Transfusion is 
initiated. Initiation of the Massive Transfusion 
Protocol also provides assurance that blood 
products will be delivered at ratios which mimic 
administration of whole blood, which has been 
shown to improve outcomes in emergent 
hemorrhage.
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To determine the effectiveness of this 
intervention at OSU Medical Center, ideas for 
future research include but are not limited to:
• Decreased time between disposition of major 
bleed and arrival of blood products at the 
bedside
• Decreased amount of crystalloid products 
utilized in patients with major bleed
• Utilization of tranexamic acid when 
appropriate
• Increasing use of more readily available O 
Positive blood in appropriate patients
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